Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
UNIGENE LABORATORIES INC (UGNE)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
| | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 17.4% | 7.6% | 23.0% | 17.1% | 29.2% | 35.4% | 28.9% | 10.1% |
| Gross profit | 82.6% | 92.4% | 77.0% | 82.9% | 70.8% | 64.6% | 71.1% | 89.9% |
| Selling, general and administrative | 90.6% | 43.3% | 67.8% | 70.2% | | | | |
| Research and development | 56.3% | 44.0% | 56.7% | 97.0% | 49.5% | | | |
| General and administrative | | | | | 41.0% | 38.3% | 106.0% | 32.5% |
| EBITDA | -126.3% | -76.4% | -92.2% | -97.2% | -25.7% | -15.2% | -181.2% | 4.2% |
| Depreciation | -22.3% | -49.8% | -3.2% | | | | | |
| EBIT | -97.1% | -12.9% | -89.1% | -97.2% | -25.7% | -15.2% | -181.2% | 4.2% |
| Pre-tax income | -376.6% | -37.5% | -293.1% | -105.6% | -36.4% | -20.4% | -203.2% | -6.4% |
| Income taxes | -13.4% | -2.9% | -6.2% | -0.5% | -4.8% | -3.5% | -8.7% | -2.9% |
| Net income | -363.3% | -34.6% | -286.9% | 0.0% | -31.6% | -16.9% | -194.5% | -3.5% |
|